RecruitingNot ApplicableNCT05319158

The Effect of the Movement Imitation Therapy in Preterm (MIT-PB) in Motor Behavior's Quality.

The Effect of the Movement Imitation Therapy for Preterm Babies (MIT-PB) on Motor Behavior Quality. Quasi-experimental Design.


Sponsor

Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta

Enrollment

36 participants

Start Date

Apr 4, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to assess the effect of a parent-administered intervention program based on MIT-PB in preterm with abnormal general movements during the preterm period. We will describe the short and long-term differences between infants exposed to MIT-PB and infants who follow current standard care.


Eligibility

Min Age: 22 WeeksMax Age: 32 Weeks

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying MIT-PB, movement imitation therapy for preterm. for people with early intervention, premature birth, and other related conditions. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 22 Weeks to 32 Weeks.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERMIT-PB, movement imitation therapy for preterm.

The instant an infant showed CS or PR movements, the therapists (or a therapist and a parent) intervened by gently guiding the infants' limbs so as to maneuver and smoothen their movements, thereby imitating normal GM sequences as closely as possible, adding variability to the movement


Locations(3)

Hospital Sant Joan de Déu

Barcelona, Barcelona, Spain

Hospital Parc Taulí de Sabadell

Sabadell, BARCELONA, Spain

Hospital Universitari Josep Trueta de Girona

Girona, Girona, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05319158


Related Trials